Premium
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply
Author(s) -
Sands Bruce E.,
Armuzzi Alessandro,
Marshall John K.,
Lindsay James O.,
Sandborn William J.,
Danese Silvio,
Panés Julián,
Bressler Brian,
Colombel JeanFrédéric,
Lawendy Nervin,
Maller Eric,
Zhang Haiying,
Chan Gary,
Salese Leonardo,
Tsilkos Konstantinos,
Marren Amy,
Su Chinyu
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15716
Subject(s) - tofacitinib , medicine , octave (electronics) , open label , corticosteroid , dermatology , surgery , randomized controlled trial , optics , rheumatoid arthritis , physics